Search the full ICD-10 catalog by:
The ICD-10-CM is a catalog of diagnosis codes used by medical professionals for medical coding and reporting in health care settings. The Centers for Medicare and Medicaid Services (CMS) maintain the catalog in the U.S. releasing yearly updates.
The new codes are for describing the infusion of tixagevimab and cilgavimab monoclonal antibody (code XW023X7), and the infusion of other new technology monoclonal antibody (code XW023Y7).
Why ICD-10 codes are important
839.
Thrombocythemia and thrombocytosis are conditions that occur when your blood has a higher-than-normal platelet count. Platelets are tiny blood cells. They are made in your bone marrow along with other kinds of blood cells.
When another disease or condition causes a high platelet count, the term "thrombocytosis" is preferred. This condition often is called secondary or reactive thrombocytosis. Secondary thrombocytosis is more common than primary thrombocythemia. Often, a high platelet count doesn't cause signs or symptoms.
Other secondary thrombocytopenia D69. 59 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM D69. 59 became effective on October 1, 2021.
Essential thrombocythemia (ET) was the most common cause of primary thrombocytosis. Among secondary, non-infectious etiologies, tissue damage was the most common, followed by malignancy and iron-deficiency anemia. The most common infectious causes of thrombocytosis were soft-tissue, pulmonary and GI infections.
The cause of this disorder is unclear but it often appears to be connected to mutations in a variety of genes. Your bone marrow produces too many of the cells that form platelets and these platelets are often abnormal.
Primary thrombocythemia also is called: Essential thrombocythemia. This term is used when a high platelet count occurs alone (that is, without other blood cell disorders).
Even though the platelet count is elevated for a short time (or even indefinitely after splenectomy), secondary thrombocytosis does not typically lead to abnormal blood clotting. Primary thrombocytosis, or essential thrombocythemia, can cause serious bleeding or clotting complications.
Thrombocytosis is an adverse prognostic factor in many types of cancer. These include breast cancer, ovarian and other gynecologic cancers, renal cell carcinoma and lung cancers.
D75. 838 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM D75.
Essential (hemorrhagic) thrombocythemia D47. 3 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM D47. 3 became effective on October 1, 2021.
2022 ICD-10-CM Diagnosis Code D75. 83: Thrombocytosis.
A type 2 excludes note represents "not included here". A type 2 excludes note indicates that the condition excluded is not part of the condition it is excluded from but a patient may have both conditions at the same time. When a type 2 excludes note appears under a code it is acceptable to use both the code ( D75.83) and the excluded code together.
D50-D89 Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
A code also note instructs that 2 codes may be required to fully describe a condition but the sequencing of the two codes is discretionary, depending on the severity of the conditions and the reason for the encounter.
D50-D89 Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
A type 2 excludes note represents "not included here". A type 2 excludes note indicates that the condition excluded is not part of the condition it is excluded from but a patient may have both conditions at the same time. When a type 2 excludes note appears under a code it is acceptable to use both the code ( D75.83) and the excluded code together.
D50-D89 Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism